Litcius/Paper detail

Drug-Tolerant Persister Cells After EGFR Tyrosine Kinase Inhibitor Treatment: Their Origin and the Influences From the Tumor Microenvironment

Hiromichi Ebi

2023Journal of Thoracic Oncology10 citationsDOIOpen Access PDF

Topics & Concepts

ReprogrammingCancer researchDrug resistanceCancer cellTumor microenvironmentCancerMedicinePhenotypeBiologyCellGeneticsTumor cellsInternal medicineGeneCancer Genomics and DiagnosticsCancer Cells and MetastasisPancreatic and Hepatic Oncology Research
Drug-Tolerant Persister Cells After EGFR Tyrosine Kinase Inhibitor Treatment: Their Origin and the Influences From the Tumor Microenvironment | Litcius